Dysregulation of the PI3K/AKT/mTOR signaling pathway has been found in most cancers, such as breast, lung, blood, ovarian, and colorectal malignancies, indicating that this pathway is worthy of exploration in a wide range of cancers (please see References [77,90] for reviews of PI3K signaling and inhibition). The gene discussed is AKT1; the disease is cancer.